Publications
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins. Cell. 187, 4305-4317.e18
(2024) Transferrin receptor targeting by de novo sheet extension. Proc Natl Acad Sci U S A. 10.1073/pnas.2021569118
(2021) NECAT
9700 S. Cass Ave.
Bldg. 436E
Argonne, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2024, NECAT
Design by FreeBiezz